Drugs/Medical Legal News Articles & Interviews

New Orleans, LA A breast implant side effects lawsuit filed in the Eastern District of Louisiana may soon join the growing list of cases to be considered as part of the federal multidistrict litigation forming in New Jersey. Seuzeneau v. Allergan USA, Inc. charges that Allergan, which marketed, advertised and sold Biocell textured breast implants, failed to disclose the connection between the implants and BIA-ALCL, a rare form of cancer.

Harrisburg, PA Only after pressure from scientists and consumers and mounting Elmiron vision loss lawsuits, Janssen Pharmaceuticals has finally updated its Elmiron interstitial cystitis drug label, adding the risk of developing permanent eye damage to its side effects. But a quick scan online shows that numerous health sites and pharmacies have not received the memo.

Hackensack, NJ On July 7, the initial case management conference for In Re: Allergan Biocell Textured Breast Implant Products Liability Litigation (the “MCL”) was held before Judge Rachelle Harz in New Jersey Superior Court in Bergen County. The consolidation of state law actions is intended to permit speedy, cost-effective and consistent management of the common issues that the breast implant side effects lawsuits are expected to share. This multicounty litigation will proceed in parallel with the multidistrict federal lawsuits (the “MDL”) that have been consolidated in Newark.

Washington, DC On April 1, the federal Food and Drug Administration asked manufacturers to withdraw Zantac and all other prescription and over-the-counter ranitidine drugs from the market immediately. It has also advised those who use OTC ranitidine medications to stop taking them immediately and patients with ranitidine prescriptions to speak with their health care providers. Zantac cancer lawsuits that cite the link between heartburn medications that contain ranitidine and various forms of cancer have been forming for months. The FDA has now finally taken affirmative steps to protect consumers.

Santa Clara, CA Back in 2017, a law was passed to protect Californians against surprise medical bills for non-emergency care. Before that, AB1611 was proposed: it was supposed to protect against emergency room overcharges but California consumers are still getting gouged by out-of-network providers.

Tampa, FL Two Zantac lawsuits recently filed allege the popular heartburn and acid reflux medication causes Zantac bladder cancer and Zantac colon cancer. Both plaintiffs claim they were exposed to dangerous amounts of  N--Nitrosodimethylamine (NDMA), a known cancer-causing chemical found in the medication.

Santa Clara, CA On the heels of studies linking the bladder drug Elmiron to vision loss, lawsuits are being filed nationwide against Janssen Pharmaceuticals, claiming the interstitial cystitis medication causes serious vision damage, namely maculopathy — a degenerative disease of the retina. Further, the drug manufacturer has been accused of knowing the Elmiron vision risks and not disclosing them.

Santa Clara, CA Several Zantac breast cancer lawsuits have been filed against the drug manufacturers, 12 years after a peer-reviewed study from the Fred Hutchinson Cancer Research Center linked Zantac with breast cancer.

San Francisco, CA Last year Zuckerberg San Francisco General Hospital reduced a patient’s emergency room charges from $20,243 bill down to $200—after the patient, Nina Dang, contacted the media. She broke her arm on the pavement in a bike accident. Can’t reach the media? Of course lawyers experienced with negotiating ER overcharges can also substantially reduce hospital costs, both for insured and uninsured patients. “It’s frustrating that I have to hire a lawyer, but so far it’s been worth it,” said another ER patient, Alexa Sulvetta.

Washington, DC Since at least last summer the FDA has known that a contaminant known as N-Nitrosodimethylamine (NDMA) was present in ranitidine medications (commonly known as the brand name Zantac), but the agency didn’t order a withdrawal of the popular heartburn drug until this month – almost a year later. Chances are, countless people who have been taking a side of a potential carcinogen with their Zantac dose each day are concerned about the possibility of developing Zantac-related cancer —and many people are filing Zantac lawsuits.